Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding SURI?
Track your performance easily
SURI Price & Analysis
SURI ETF Chart & Stats
Day’s Range― - ―
52-Week Range$16.42 - $27.52
Previous Close$16.49
VolumeN/A
Average Volume (3M)5.67K
AUM74.46M
NAV16.50
Expense Ratio2.54%
Holdings Count23
Beta0.86
Inception DateFeb 08, 2023
Last Dividend Ex-Date
Sep 25, 2024Dividend Yield
(19.85%)Shares Outstanding4,490,909
Standard Deviation0.09
10 Day Avg. Volume2,742
30 Day Avg. Volume5,674
Alpha-0.01
Simplify Propel Opportunities ETF (SURI) Fund Flow Chart
Simplify Propel Opportunities ETF (SURI) 1 year Net Flows: $576K
SURI ETF News
PremiumCompany Announcements
Applied Therapeutics Faces Leadership Changes and Regulatory Hurdles
SURI ETF FAQ
What was SURI’s price range in the past 12 months?
SURI lowest ETF price was $16.42 and its highest was $27.52 in the past 12 months.
What is the AUM of SURI?
As of Dec 19, 2024 The AUM of SURI is 74.46M.
Is SURI overvalued?
According to Wall Street analysts SURI’s price is currently Undervalued.
Does SURI pay dividends?
SURI pays a Quarterly dividend of $0.68 which represents an annual dividend yield of 19.85%. See more information on SURI dividends here
How many shares outstanding does SURI have?
SURI has 4,490,909 shares outstanding.
Which hedge fund is a major shareholder of SURI?
Currently, no hedge funds are holding shares in SURI
SURI ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Plains GP Holdings LP
31.05%
Madrigal
9.22%
Akero Therapeutics
8.76%
U.S. Dollar
8.35%
Phathom Pharmaceuticals, Inc.
6.14%
Avidity Biosciences Inc
5.24%
Ardelyx Inc
4.36%
Tscan Therapeutics, Inc.
4.14%
Applied Therapeutics
3.88%
N/A
3.37%
Total84.51%
ETF Description
Simplify Propel Opportunities ETF
SURI employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities. Derivatives may also be used to leverage exposure and hedge against declines.